Originally from Queensland, I am an early career, post-doctoral researcher at the Children's Cancer Institute. My PhD, completed at Griffith University and QIMR Berghofer, focused on delineating a role for cellular prion protein in colorectal and breast cancer chemotherapeutic resistance. After completing my PhD in 2016, I joined Mater Research Institute where I assessed the functional consequences of a variant in ATM on DNA damage response signalling in melanoma. In 2017, I moved to Sydney to take a position at Children's Cancer Institute where I am currently involved in several projects aimed at improving the outcome of patients with high-risk neuroblastoma.
CIB - NHMRC New Ideas Grant “Improving induction therapy for high-risk neuroblastoma through bypass or inhibition of P-glycoprotein”, 2020-2021 (CIA Dr Jamie Fletcher, CIC Dr Alvin Kamili).